Hangzhou Diagens Biotechnology Co., Ltd./ADR HGZDY

The SEC does not publish structured financial data (XBRL) for Hangzhou Diagens Biotechnology Co., Ltd./ADR, so there are no statement tables here. This is common for foreign companies that trade over the counter and for filers that only submit documents. Its filings are still listed below and on SEC EDGAR.

Recent SEC filings

Recent SEC filings
Form Description Filed Period
F-6EF Filing Jul 1, 2026 —
F-6EF Filing Apr 14, 2026 —

Company profile

Listed as
HGZDY (OTC)
Fiscal year ends
December 31
Incorporated in
China
Headquarters
Hangzhou
SEC CIK
2128813

Source: SEC EDGAR filings. This is company-reported data, not investment advice.